HLA-G and cancer: Many mechanisms of immunotherapy resistance have been shown to be associated with immune evasion, showing (1) abrogated expression of cancer antigens; (2) decreased antigen presentation secondary to major histocompatibility complex (MHC), β2-microglobulin alterations; (3).